logo

For the Inventor, By the Inventor

Oberwil, Switzerland

Raymond Bernasconi

USPTO Granted Patents = 13

Average Co-Inventor Count = 2.8

ph-index = 7

Forward Citations = 140(Granted Patents)


Location History:

  • Oberwill, CH (1981)
  • Oberwil, CH (1976 - 1996)

Company Filing History:

goldMedal13 out of 6,850 
 
Ciba-geigy Corporation
 patents

Years Active: 1976-1996

Loading Chart...
13 patents (USPTO):Explore Patents
1. 5545631 - N-substituted aminoalkanephosphinic acid derivatives, compositions (1996-08-13),
2. 5407922 - Certain N-substituted-amino-alkane phosphinic acid derivatives having (1995-04-18),
3. 5229379 - Certain N-substituted-amino-alkane phosphinic acid derivatives having (1993-07-20),
4. 4600719 - Tetrahydropyridine and piperidine derivatives (1986-07-15),
5. 4396621 - Certain 2-oxo-2,3-dihydro-3-benzothiophene-carboxamides and their (1983-08-02),
6. 4320138 - Oxothia compounds (1982-03-16),
7. 4260779 - Oxothia compounds (1981-04-07),
8. 4259338 - Benzofuranyl-tetrahydropyridines and -piperidines, their acid addition (1981-03-31),
9. 4210655 - Anti-depressant benzofuranyl piperidines (1980-07-01),
10. 4187234 - Alkanecarboxylic acid compounds which have benzofuranyl or benzothienyl (1980-02-05),
11. 4045580 - Pharmaceutical preparation using (1977-08-30),
12. 4017542 - 9-(2-Hydroxy-3-amino-propyl)-9,10-dihydro-9,10-ethano-anthracenes and (1977-04-12),
13. 3974280 - Benzothiophenes (1976-08-10),

Title: Innovations in Pharmaceutical Chemistry: The Contributions of Raymond Bernasconi

Introduction

Raymond Bernasconi is a prominent inventor based in Oberwil, Switzerland, known for his contributions to pharmaceutical chemistry. With a remarkable portfolio of 13 patents, his work has significantly advanced the field, particularly in the development of compounds that show promise in treating various medical conditions.

Latest Patents

Bernasconi's latest innovations pertain to N-substituted aminoalkanephosphinic acid derivatives, which possess GABA_B-antagonistic properties. These compounds, defined by complex chemical structures, are designed to serve as active ingredients in medicaments aimed at treating the 'petit mal' type of epilepsy. His innovative approach also encompasses novel processes for synthesizing these compounds, highlighting his expertise in medicinal chemistry.

Career Highlights

Throughout his career, Bernasconi has demonstrated a steadfast commitment to innovation in the pharmaceutical industry. He has been associated with Ciba-Geigy Corporation, a major player in the chemical and pharmaceutical sector, where he has been instrumental in developing groundbreaking therapeutic solutions.

Collaborations

Bernasconi has collaborated with notable colleagues such as Karl Schenker and Pier G Ferrini. These partnerships have fostered an environment of sharing ideas and advancing research, culminating in several successful patents that contribute to the scientific community.

Conclusion

Raymond Bernasconi's work stands as a testament to the impact of innovative thinking in the field of pharmaceutical chemistry. His patented compounds and ongoing research efforts underscore the significant advances he has made in the treatment of epilepsy and other medical conditions. As the landscape of pharmaceutical inventions continues to evolve, Bernasconi's contributions remain a pivotal part of this progression.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…